Yep still going. M2R also got on us also. Share price down nearly 100% and the CEO is taking in $400k a year.
- Forums
- ASX - By Stock
- Ann: High grade Niobium results from Equador - Brazil
Yep still going. M2R also got on us also. Share price down...
-
-
- There are more pages in this discussion • 203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SUM (ASX) to my watchlist
|
|||||
Last
18.0¢ |
Change
0.010(5.88%) |
Mkt cap ! $12.93M |
Open | High | Low | Value | Volume |
17.5¢ | 18.5¢ | 17.5¢ | $50.12K | 277.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 100000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24999 | 0.180 |
2 | 40000 | 0.175 |
2 | 89998 | 0.170 |
3 | 69702 | 0.165 |
3 | 100000 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 100000 | 2 |
0.190 | 75800 | 4 |
0.195 | 100000 | 1 |
0.200 | 275100 | 4 |
0.205 | 50000 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
SUM (ASX) Chart |